Table 1.
Expression of SKIP expression in bladder cancer patients according to clinicopathologic characteristics | ||||
---|---|---|---|---|
| ||||
NO | SKIP expression | p | ||
|
||||
High N (%) | Low N (%) | |||
Sex | 1.000 | |||
Male | 55 | 17 | 38 | |
Female | 15 | 5 | 10 | |
Age (y) | 0.128 | |||
≤45 | 9 | 5 | 4 | |
>45 | 61 | 17 | 44 | |
Differentiation | 0.001* | |||
Grade 1/2 | 51 | 10 | 41 | |
Grade 3 | 19 | 12 | 7 | |
Tumor types | 0.731 | |||
NMIBC | 59 | 18 | 41 | |
MIBC | 11 | 4 | 7 | |
Distant metastasis | 0.448 | |||
- | 61 | 18 | 43 | |
+ | 9 | 4 | 5 | |
Recurrence | 0.004* | |||
- | 38 | 6 | 32 | |
+ | 32 | 16 | 16 |
Statistical analyses were performed by the Pearson χ2 test
P<0.05 was considered significant.